Serotonin and vasovagal syncope.
Bezold-Jarisch reflex
Clinical trials
Serotonin
Vasovagal syncope
Journal
Clinical autonomic research : official journal of the Clinical Autonomic Research Society
ISSN: 1619-1560
Titre abrégé: Clin Auton Res
Pays: Germany
ID NLM: 9106549
Informations de publication
Date de publication:
09 Jul 2024
09 Jul 2024
Historique:
received:
04
04
2024
accepted:
27
06
2024
medline:
9
7
2024
pubmed:
9
7
2024
entrez:
9
7
2024
Statut:
aheadofprint
Résumé
The goal of this manuscript was to review the biological and clinical evidence that serotonin neurotransmission might play an important role in the physiology and treatment of vasovagal syncope. The authors reviewed PubMed and handsearches of secondary sources for papers related to the Bezold-Jarisch reflex and serotonin, the plausible involvement of the Bezold-Jarisch reflex in vasovagal syncope, and three lines of clinical evidence involving serotonin and the syncope. The Bezold-Jarisch reflex was first described following the infusion of veratrum alkaloids into animals in the 19th century. The reflex is triggered by serotonin stimulation chemoreceptors and mechanoreceptors in the the left ventricle. The afferent component of the reflex is carried by unmyelinated type C vagal nerve fibers, which results in parasympathetic efferent stimulation that causes bradycardia. The similarity of the combination of hypotension and bradycardia in the Bezold-Jarisch reflex and in vasovagal syncope led to the suggestion that the reflex was the cause of the syndrome. Three lines of evidence implicate the serotonin 5HT3 receptors in the heart in the reflex. There is genetic and physiologic evidence for the serotonin 5HT1A and 5HT3 receptors and the serotonin reuptake transporter (SERT). Acute blockade of SERT induces vasovagal syncope in humans undergoing head-up tilt table testing, and SERT inhibition reduces hypotension and bradycardia during spinal anaesthesia. Finally, three randomized clinical trials of SERT inhibitors uniformly reported that they significantly reduce the likelihood of vasovagal syncope recurrences. Multiple lines of evidence implicate serotonin neurotransmission in the cause of vasovagal syncope.
Identifiants
pubmed: 38980470
doi: 10.1007/s10286-024-01052-1
pii: 10.1007/s10286-024-01052-1
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Springer-Verlag GmbH Germany.
Références
Lovelace JW, Ma J, Yadav S et al (2023) Vagal sensory neurons mediate the Bezold-Jarisch reflex and induce syncope. Nature 623(7986):387–396. https://doi.org/10.1038/s41586-023-06680-7
doi: 10.1038/s41586-023-06680-7
pubmed: 37914931
pmcid: 10632149
Pires JG, Silva SR, Ramage AG, Futuro-Neto HA (1998) Evidence that 5-HT3 receptors in the nucleus tractus solitarius and other brainstem areas modulate the vagal bradycardia evoked by activation of the von Bezold-Jarisch reflex in the anesthetized rat. Brain Res 791(1–2):229–234. https://doi.org/10.1016/s0006-8993(98)00109-7
doi: 10.1016/s0006-8993(98)00109-7
pubmed: 9593908
Thames MD, Klopfenstein HS, Abboud FM, Mark AL, Walker JL (1978) Preferential distribution of inhibitory cardiac receptors with vagal afferents to the inferoposterior wall of the left ventricle activated during coronary occlusion in the dog. Circ Res 43(4):512–519. https://doi.org/10.1161/01.res.43.4.512
doi: 10.1161/01.res.43.4.512
pubmed: 688555
Arrowood JA, Mohanty PK, Hodgson JM, Dibner-Dunlap ME, Thames MD (1989) Ventricular sensory endings mediate reflex bradycardia during coronary arteriography in humans. Circulation 80(5):1293–1300. https://doi.org/10.1161/01.cir.80.5.1293
doi: 10.1161/01.cir.80.5.1293
pubmed: 2805265
Serletis A, Rose S, Sheldon AG, Sheldon RS (2006) Vasovagal syncope in medical students and their first-degree relatives. Eur Heart J 27(16):1965–1970. https://doi.org/10.1093/eurheartj/ehl147
doi: 10.1093/eurheartj/ehl147
pubmed: 16837484
Sheldon R, Rose S, Connolly S, Ritchie D, Koshman ML, Frenneaux M (2006) Diagnostic criteria for vasovagal syncope based on a quantitative history. Eur Heart J 27(3):344–350. https://doi.org/10.1093/eurheartj/ehi584
doi: 10.1093/eurheartj/ehi584
pubmed: 16223744
Raj PL, Sheldon RS, Lorenzetti D, Jardine DL, Raj SR, Vandenberk B (2022) Sleep syncope-A systematic review. Front Cardiovasc Med 9:973368. https://doi.org/10.3389/fcvm.2022.973368
doi: 10.3389/fcvm.2022.973368
pubmed: 36277790
pmcid: 9582595
Sheldon RS, Gerull B (2021) Genetic markers of vasovagal syncope. Auton Neurosci. https://doi.org/10.1016/j.autneu.2021.102871
doi: 10.1016/j.autneu.2021.102871
pubmed: 34856496
pmcid: 8455430
Sahota IS, Maxey C, Pournazari P, Sheldon RS (2017) Clusters, gaps, and randomness: vasovagal syncope recurrence patterns. JACC Clin Electrophysiol 3(9):1046–1053. https://doi.org/10.1016/j.jacep.2017.02.008
doi: 10.1016/j.jacep.2017.02.008
pubmed: 29759709
Shen WK, Sheldon RS, Benditt DG et al (2017) 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. Circulation 136(5):e25–e59. https://doi.org/10.1161/CIR.0000000000000498
doi: 10.1161/CIR.0000000000000498
pubmed: 28280232
Jorge JG, Pournazari P, Raj SR, Maxey C, Sheldon RS (2020) Frequency of injuries associated with syncope in the prevention of syncope trials. Europace 22(12):1896–1903. https://doi.org/10.1093/europace/euaa246
doi: 10.1093/europace/euaa246
pubmed: 32954415
pmcid: 7758472
Jorge JG, Raj SR, Teixeira PS, Teixeira JAC, Sheldon RS (2021) Likelihood of injury due to vasovagal syncope: a systematic review and meta-analysis. Europace 23(7):1092–1099. https://doi.org/10.1093/europace/euab041
doi: 10.1093/europace/euab041
pubmed: 33693816
Jorge J, Raj S, Liang Z, Sheldon R (2022) Quality of life and injury due to vasovagal syncope. Clin Auton Res 32(2):147–149. https://doi.org/10.1007/s10286-022-00856-3
doi: 10.1007/s10286-022-00856-3
pubmed: 35254551
Rose MS, Koshman ML, Spreng S, Sheldon R (2000) The relationship between health-related quality of life and frequency of spells in patients with syncope. J Clin Epidemiol 53(12):1209–1216. https://doi.org/10.1016/s0895-4356(00)00257-2
doi: 10.1016/s0895-4356(00)00257-2
pubmed: 11146266
Sheldon RS, Grubb BP, Olshansky B et al (2015) 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm 12(6):e41–e63. https://doi.org/10.1016/j.hrthm.2015.03.029
doi: 10.1016/j.hrthm.2015.03.029
pubmed: 25980576
pmcid: 5267948
Ng J, Sheldon RS, Ritchie D, Raj V, Raj SR (2019) Reduced quality of life and greater psychological distress in vasovagal syncope patients compared to healthy individuals. Pacing Clin Electrophysiol 42(2):180–188. https://doi.org/10.1111/pace.13559
doi: 10.1111/pace.13559
pubmed: 30488466
Stewart JM, McLeod KJ, Sanyal S, Herzberg G, Montgomery LD (2004) Relation of postural vasovagal syncope to splanchnic hypervolemia in adolescents. Circulation 110(17):2575–2581. https://doi.org/10.1161/01.CIR.0000145543.88293.21
doi: 10.1161/01.CIR.0000145543.88293.21
pubmed: 15492310
Verheyden B, Liu J, van Dijk N et al (2008) Steep fall in cardiac output is main determinant of hypotension during drug-free and nitroglycerine-induced orthostatic vasovagal syncope. Heart Rhythm 5(12):1695–1701. https://doi.org/10.1016/j.hrthm.2008.09.003
doi: 10.1016/j.hrthm.2008.09.003
pubmed: 19084808
Jardine DL, Wieling W, Brignole M, Lenders JWM, Sutton R, Stewart J (2018) The pathophysiology of the vasovagal response. Heart Rhythm 15(6):921–929. https://doi.org/10.1016/j.hrthm.2017.12.013
doi: 10.1016/j.hrthm.2017.12.013
pubmed: 29246828
Stewart JM, Medow MS, Sutton R, Visintainer P, Jardine DL, Wieling W (2017) Mechanisms of vasovagal syncope in the young: reduced systemic vascular resistance versus reduced cardiac output. J Am Heart Assoc. https://doi.org/10.1161/JAHA.116.004417
doi: 10.1161/JAHA.116.004417
pubmed: 29263032
pmcid: 5779002
Fucà G, Dinelli M, Suzzani P, Scarfò S, Tassinari F, Alboni P (2006) The venous system is the main determinant of hypotension in patients with vasovagal syncope. Europace 8(10):839–845. https://doi.org/10.1093/europace/eul095
doi: 10.1093/europace/eul095
pubmed: 16916860
Nigro G, Russo V, Rago A et al (2012) The main determinant of hypotension in nitroglycerine tilt-induced vasovagal syncope. Pacing Clin Electrophysiol 35(6):739–748. https://doi.org/10.1111/j.1540-8159.2012.03388.x
doi: 10.1111/j.1540-8159.2012.03388.x
pubmed: 22519305
van Dijk JG, Ghariq M, Kerkhof FI et al (2020) Novel methods for quantification of vasodepression and cardioinhibition during tilt-induced vasovagal syncope. Circ Res 127(5):e126–e138. https://doi.org/10.1161/CIRCRESAHA.120.316662
doi: 10.1161/CIRCRESAHA.120.316662
pubmed: 32460687
Sheldon RS, Lei L, Guzman JC et al (2019) A proof of principle study of atomoxetine for the prevention of vasovagal syncope: the prevention of syncope Trial VI. Europace 21(11):1733–1741. https://doi.org/10.1093/europace/euz250
doi: 10.1093/europace/euz250
pubmed: 31538180
Kuriachan V, Sheldon RS, Platonov M (2008) Evidence-based treatment for vasovagal syncope. Heart Rhythm 5(11):1609–1614. https://doi.org/10.1016/j.hrthm.2008.08.023
doi: 10.1016/j.hrthm.2008.08.023
pubmed: 18984541
Sheldon R, Faris P, Tang A et al (2021) Midodrine for the prevention of vasovagal syncope : a randomized clinical trial. Ann Intern Med 174(10):1349–1356. https://doi.org/10.7326/M20-5415
doi: 10.7326/M20-5415
pubmed: 34339231
Lei LY, Raj SR, Sheldon RS (2022) Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis. Europace 24(7):1171–1178. https://doi.org/10.1093/europace/euab323
doi: 10.1093/europace/euab323
pubmed: 35025999
pmcid: 9301979
Sheldon R, Raj SR, Rose MS et al (2016) Fludrocortisone for the Prevention of vasovagal syncope: a randomized. Placebo-Controlled Trial J Am Coll Cardiol 68(1):1–9. https://doi.org/10.1016/j.jacc.2016.04.030
doi: 10.1016/j.jacc.2016.04.030
pubmed: 27364043
Baron-Esquivias G, Morillo CA, Moya-Mitjans A et al (2017) Dual-chamber pacing with closed loop stimulation in recurrent reflex vasovagal syncope: the Spain study. J Am Coll Cardiol 70(14):1720–1728. https://doi.org/10.1016/j.jacc.2017.08.026
doi: 10.1016/j.jacc.2017.08.026
pubmed: 28958328
Brignole M, Russo V, Arabia F et al (2021) Cardiac pacing in severe recurrent reflex syncope and tilt-induced asystole. Eur Heart J 42(5):508–516. https://doi.org/10.1093/eurheartj/ehaa936
doi: 10.1093/eurheartj/ehaa936
pubmed: 33279955
Lei LY, Raj SR, Sheldon RS (2020) Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in young and adult subjects: a systematic review and meta-analysis. Heart Rhythm 17(7):1151–1158. https://doi.org/10.1016/j.hrthm.2020.02.033
doi: 10.1016/j.hrthm.2020.02.033
pubmed: 32151742
pmcid: 7335357
Sheldon RS, Seifer C, Parkash R, Sandhu RK, Hamzeh R, Raj SR (2023) Atomoxetine for suppression of vasovagal syncope. Clin Auton Res 33(1):23–28. https://doi.org/10.1007/s10286-022-00905-x
doi: 10.1007/s10286-022-00905-x
pubmed: 36401665
Sheldon RS, Ritchie D, McRae M, Raj S (2013) Norepinephrine transport inhibition for treatment of vasovagal syncope. J Cardiovasc Electrophysiol 24(7):799–803. https://doi.org/10.1111/jce.12111
doi: 10.1111/jce.12111
pubmed: 23444896
Grancai D, Grancaiová Z (1994) Veratrum alkaloids. Ceska Slov Farm 43(4):147–154
pubmed: 8069520
Aviado DM, Guevara AD, Bezold-Jarisch T, reflex (2001) A historical perspective of cardiopulmonary reflexes. Ann N Y Acad Sci 940:48–58
doi: 10.1111/j.1749-6632.2001.tb03666.x
pubmed: 11458703
Yamano M, Kamato T, Nishida A et al (1994) Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats. Jpn J Pharmacol 65(3):241–248. https://doi.org/10.1254/jjp.65.241
doi: 10.1254/jjp.65.241
pubmed: 7799524
Chianca Júnior DA, Cunha-Melo JR, Freire-Maia L (1985) The Bezold-Jarisch-like effect induced by veratridine and its potentiation by scropion toxin in the rat. Braz J Med Biol Res 18(2):237–248
pubmed: 3830286
Callera JC, Sévoz C, Laguzzi R, Machado BH (1997) Microinjection of a serotonin3 receptor agonist into the NTS of unanesthetized rats inhibits the bradycardia evoked by activation of the baro- and chemoreflexes. J Auton Nerv Syst 63(3):127–136. https://doi.org/10.1016/s0165-1838(96)00140-3
doi: 10.1016/s0165-1838(96)00140-3
pubmed: 9138244
Delbrück SJ, Wendel B, Grunewald I et al (1997) A novel allelic variant of the human serotonin transporter gene regulatory polymorphism. Cytogenet Cell Genet 79(3–4):214–220. https://doi.org/10.1159/000134726
doi: 10.1159/000134726
pubmed: 9605856
Klauck SM, Poustka F, Benner A, Lesch KP, Poustka A (1997) Serotonin transporter (5-HTT) gene variants associated with autism? Hum Mol Genet 6(13):2233–2238. https://doi.org/10.1093/hmg/6.13.2233
doi: 10.1093/hmg/6.13.2233
pubmed: 9361027
Castillero E, Fitzpatrick E, Keeney SJ et al (2023) Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation. Sci Transl Med. https://doi.org/10.1126/scitranslmed.adc9606
doi: 10.1126/scitranslmed.adc9606
pubmed: 36599005
pmcid: 9896655
McHugh RK, Hofmann SG, Asnaani A, Sawyer AT, Otto MW (2010) The serotonin transporter gene and risk for alcohol dependence: a meta-analytic review. Drug Alcohol Depend 108(1–2):1–6. https://doi.org/10.1016/j.drugalcdep.2009.11.017
doi: 10.1016/j.drugalcdep.2009.11.017
pubmed: 20060655
pmcid: 2835838
Mortensen OV, Kristensen AS, Rudnick G, Wiborg O (1999) Molecular cloning, expression and characterization of a bovine serotonin transporter. Mol Brain Res 71(1):120–126. https://doi.org/10.1016/s0169-328x(99)00178-3
doi: 10.1016/s0169-328x(99)00178-3
pubmed: 10407194
Riad M, Garcia S, Watkins KC et al (2000) Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neurol 417(2):181–194
doi: 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A
pubmed: 10660896
Polter AM, Li X (2010) 5-HT1A receptor-regulated signal transduction pathways in brain. Cell Signal 22(10):1406–1412. https://doi.org/10.1016/j.cellsig.2010.03.019
doi: 10.1016/j.cellsig.2010.03.019
pubmed: 20363322
pmcid: 2903656
Strobel A, Gutknecht L, Rothe C et al (2003) Allelic variation in 5-HT1A receptor expression is associated with anxiety-and depression-related personality traits. J Neural Transm 110(12):1445–1453. https://doi.org/10.1007/s00702-003-0072-0
doi: 10.1007/s00702-003-0072-0
pubmed: 14666415
Blier P, Bergeron R, de Montigny C (1997) Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response. Neuropsychopharmacology 16(5):333–338. https://doi.org/10.1016/S0893-133X(96)00242-4
doi: 10.1016/S0893-133X(96)00242-4
pubmed: 9109104
Jeggo RD, Kellett DO, Wang Y, Ramage AG, Jordan D (2005) The role of central 5-HT3 receptors in vagal reflex inputs to neurones in the nucleus tractus solitarius of anaesthetized rats. J Physiol 566:939–953. https://doi.org/10.1113/jphysiol.2005.085845
doi: 10.1113/jphysiol.2005.085845
pubmed: 15905216
pmcid: 1464782
Merahi N, Orer HS, Laporte AM, Gozlan H, Hamon M, Laguzzi R (1992) Baroreceptor reflex inhibition induced by the stimulation of serotonin3 receptors in the nucleus tractus solitarius of the rat. Neuroscience 46(1):91–100. https://doi.org/10.1016/0306-4522(92)90011-p
doi: 10.1016/0306-4522(92)90011-p
pubmed: 1350667
Comet MA, Laguzzi R, Hamon M, Sévoz-Couche C (2005) Functional interaction between nucleus tractus solitarius NK1 and 5-HT3 receptors in the inhibition of baroreflex in rats. Cardiovasc Res 65(4):930–939. https://doi.org/10.1016/j.cardiores.2004.11.012
doi: 10.1016/j.cardiores.2004.11.012
pubmed: 15721874
Arikan E, Yeşil M, Apali Z, Postaci N, Bayata S (2009) Vasovagal syncope in monozygotic twins. Anatol J Cardiol 9(1):61–62
Márquez MF, Urias KI, Hermosillo AG et al (2005) Familial vasovagal syncope. Europace 7(5):472–474. https://doi.org/10.1016/j.eupc.2005.05.004
doi: 10.1016/j.eupc.2005.05.004
pubmed: 16087112
Sheldon R, Rose MS, Ritchie D et al (2019) Genetic association study in multigenerational kindreds with vasovagal syncope: evidence for involvement of sex-specific serotonin signaling. Circ Arrhythm Electrophysiol 12(1):e006884. https://doi.org/10.1161/CIRCEP.118.006884
doi: 10.1161/CIRCEP.118.006884
pubmed: 30636478
Hall KT, Lembo AJ, Kirsch I et al (2012) Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS ONE 7(10):e48135. https://doi.org/10.1371/journal.pone.0048135
doi: 10.1371/journal.pone.0048135
pubmed: 23110189
pmcid: 3479140
Theodorakis GN, Markianos M, Livanis EG, Zarvalis E, Flevari P, Kremastinos DT (1998) Central serotonergic responsiveness in neurocardiogenic syncope: a clomipramine test challenge. Circulation 98(24):2724–2730. https://doi.org/10.1161/01.cir.98.24.2724
doi: 10.1161/01.cir.98.24.2724
pubmed: 9851959
Theodorakis GN, Markianos M, Zarvalis E, Livanis EG, Flevari P, Kremastinos DT (2000) Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syndrome. J Am Coll Cardiol 36(1):174–178. https://doi.org/10.1016/s0735-1097(00)00719-1
doi: 10.1016/s0735-1097(00)00719-1
pubmed: 10898430
Gao L, Zheng G, Han J, Wang Y, Zheng J (2015) Effects of prophylactic ondansetron on spinal anesthesia-induced hypotension: a meta-analysis. Int J Obstet Anesth 24(4):335–343. https://doi.org/10.1016/j.ijoa.2015.08.012
doi: 10.1016/j.ijoa.2015.08.012
pubmed: 26421701
Heesen M, Klimek M, Hoeks SE, Rossaint R (2016) Prevention of spinal anesthesia-induced hypotension during cesarean delivery by 5-Hydroxytryptamine-3 receptor antagonists: a systematic review and Meta-analysis and meta-regression. Anesth Analg 123(4):977–988. https://doi.org/10.1213/ANE.0000000000001511
doi: 10.1213/ANE.0000000000001511
pubmed: 27537930
Tubog TD, Bramble RS (2022) Ondansetron reduces the incidence of hypotension after spinal anaesthesia in non-caesarean delivery: a systematic review and meta-analysis. J Perioper Pract 32(3):29–40. https://doi.org/10.1177/1750458920964157
doi: 10.1177/1750458920964157
Crystal GJ, Salem MR (2012) The Bainbridge and the “reverse” Bainbridge reflexes: history, physiology, and clinical relevance. Anesth Analg 114(3):520–532. https://doi.org/10.1213/ANE.0b013e3182312e21
doi: 10.1213/ANE.0b013e3182312e21
pubmed: 21965361
Raj P, Lei L, Flevaris P, Raj S, Sheldon R (2023) Serotonin reuptake inhibition for the prevention of vasovagal syncope: a systematic review and meta-analysis. Clin Auton Res 33(6):811–819. https://doi.org/10.1007/s10286-023-01000-5
doi: 10.1007/s10286-023-01000-5
pubmed: 37971641
Di Girolamo E, Di Iorio C, Sabatini P, Leonzio L, Barbone C, Barsotti A (1999) Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 33(5):1227–1230. https://doi.org/10.1016/s0735-1097(98)00694-9
doi: 10.1016/s0735-1097(98)00694-9
pubmed: 10193720
Theodorakis GN, Leftheriotis D, Livanis EG et al (2006) Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study. Europace 8(3):193–198. https://doi.org/10.1093/europace/euj041
doi: 10.1093/europace/euj041
pubmed: 16627439
Flevari P, Leftheriotis D, Repasos E, Katsaras D, Katsimardos A, Lekakis J (2017) Fluoxetine vs. placebo for the treatment of recurrent vasovagal syncope with anxiety sensitivity. Europace 19(1):127–131. https://doi.org/10.1093/europace/euw153
doi: 10.1093/europace/euw153
pubmed: 27702846
Benmansour S, Owens WA, Cecchi M, Morilak DA, Frazer A (2002) Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 22(15):6766–6772. https://doi.org/10.1523/JNEUROSCI.22-15-06766.2002
doi: 10.1523/JNEUROSCI.22-15-06766.2002
pubmed: 12151556
pmcid: 6758131
Curran KP, Chalasani SH (2012) Serotonin circuits and anxiety: what can invertebrates teach us? Invertebr Neurosci 12(2):81–92. https://doi.org/10.1007/s10158-012-0140-y
doi: 10.1007/s10158-012-0140-y